NCT05989022View on ClinicalTrials.gov

Comparison of Low-dose Spiral Breast CT With MRI in Major Indications of MRI for Breast Diagnostics

NARecruitingINTERVENTIONAL
Enrollment

428

Participants

Timeline

Start Date

November 24, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Breast Cancer Diagnosis
Interventions
DIAGNOSTIC_TEST

Injection of contrast enhancing agent Gadovist for MRI investigation

Image enhancing contrast agent will be injected to enhance MRI resolution in breast cancer diagnosis

DIAGNOSTIC_TEST

Injection of contrast enhancing agent Imeron for B-CT investigation

Image enhancing contrast agent will be injected to enhance B-CT resolution in breast cancer diagnosis

Trial Locations (4)

91054

RECRUITING

Radiologisches Institut Universitätsklinikum Erlangen, Erlangen

93059

RECRUITING

DRZ Die Radiologen, Regensburg

9728 NT

RECRUITING

Stichting Martini Ziekenhuis, Groningen

2333 ZA

RECRUITING

Leiden University Medical Centre, Leiden

Sponsors

Collaborators (1)

RQM+
All Listed Sponsors
collaborator

CRO Dr. med Kottmann GmbH & Co. KG

INDUSTRY

collaborator

RQM+

INDUSTRY

lead

AB-CT - Advanced Breast-CT GmbH

INDUSTRY

NCT05989022 - Comparison of Low-dose Spiral Breast CT With MRI in Major Indications of MRI for Breast Diagnostics | Biotech Hunter | Biotech Hunter